With a Massive 19.5% CAGR, Global Liver Cancer Therapeutics Market Size Worth US$ 8.9 billion by 2030

| Source: Growth Plus Reports Growth Plus Reports

Pune, Sept. 20, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global liver cancer therapeutics market is expected to clock at US$ 8.9 billion by 2030 and to grow at a CAGR of 19.5% during the forecast period. Owing to the high prevalence of liver cancer and robust investments in R&D activities to develop drugs for liver cancer treatment. This exclusive information is published by Growth Plus Reports in its report titled “Liver Cancer Therapeutics Market – Global Outlook & Forecast 2022-2030”

Request to Sample PDF Brochure: https://growthplusreports.com/inquiry/request-sample/liver-cancer-therapeutics-market/7811

Growth Drivers

The market for liver cancer therapies is driven by the high prevalence and rising incidence rates of liver cancer worldwide. The development of novel innovative therapeutic drugs, strong clinical pipeline of therapeutic drugs, an increase in awareness among people around the world, and favorable government support are likely to contribute to the growth of the liver cancer therapeutics market. The high prevalence of metastatic cancer that spreads from other parts of the body such as breast cancer, colon cancer, or lung cancer is likely to drive the market for liver cancer therapeutics during the forecast period.

The global liver cancer therapeutics market has been analyzed from three perspectives: therapy type, end user, and region.

Liver Cancer Therapeutics Market Report Scope & Strategic Insights:

Report CoverageDetails
Market Size Value inUS$ 1.8 Billion in 2021
Market Size Value byUS$ 8.9 Billion by 2030
Growth rateCAGR of 19.5% from 2022 to 2030
Forecast Period2022-2030
Base Year2021
Historical data availableYes
Segments coveredTherapy Type, Distribution Channel, and Region
Regional scopeNorth America, Europe, Asia Pacific, and the Rest of the World (ROW)
Country scopeUS, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report CoverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends

Excerpts from ‘By Therapy Type Segmentation’

The global liver cancer therapeutics market is divided into:

  • Chemotherapy
  • Immunotherapy
  • Targeted Therapy

The targeted therapy segment dominates the global market. Since the therapy focuses on invading the target tumor cells and eliminating the side effects. However, during the forecast period, the immunotherapy market is expected to grow at a high CAGR due to new innovations in liver cancer treatment.

Inquiry Before Buying: https://growthplusreports.com/inquiry/before-buying/liver-cancer-therapeutics-market/7811

Excerpts from ‘By Distribution Channel Segmentation’

The global liver cancer therapeutics market is divided into three distinct distribution channels, namely:

  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy

It has been analyzed that the hospital pharmacy segment dominates the global market because of the preference of patient to visit hospital for the treatment, due to the presence of highly skilled professionals and technologically advanced diagnostic equipments. This dominance is also due to the high sales of prescription-drugs in the hospital. However, the online pharmacy segment is expected to witness a high growth rate due to availability of drugs online and increased awareness amongst population.

Excerpts from ‘By Region Segmentation’

Based on region, the global market has been segmented into:

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Due to the rapidly rising number of liver cancer patients in densely populated nations like India, China, and Hong Kong as well as the rapidly expanding infrastructure for health care, the liver cancer therapeutics market in the Asia Pacific is predicted to grow at a high CAGR during the forecast period. One of the major variables influencing the liver cancer therapies market in Asia Pacific throughout the course of the projection is the high prevalence of secondary metastatic cancer in the area.

Excerpts from ‘Competitive Landscape’

The prominent players operating in the global liver cancer therapeutics market are:

  • Pfizer Inc
  • Bristol-Myers & Squibb Company
  • Exelixis Inc
  • Merck Sharp & Dohme Corp
  • Eli Lilly & Company
  • F. Hoffman-La Roche Ltd
  • Eisai Co., Ltd
  • Celgene Corporation
  • Amgen Inc
  • Onyx Pharmaceuticals, Inc

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem 
    2. Timeline Under Consideration
      1. Historical Years – 2020
      2. Base Year – 2021
      3. Forecasted Years – 2022 to 2030
  1. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions       
  1. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2021) 
  1. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  1. GLOBAL LIVER CANCER THERAPEUTICS MARKET - ANALYSIS & FORECAST, BY THERAPY TYPE
    1. Chemotherapy
    2. Immunotherapy
    3. Targeted Therapy

VALUE PROPOSITIONS RELATED TO THE REPORT:

  • Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
  • Comprehensive quantitative and qualitative insights at segment and sub-segment level
  • Covid 19 impact trends and perspective
  • Granular insights at global/regional/country level
  • Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
  • Blanket coverage on competitive landscape
  • Winning imperatives
  • Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

CUSTOMIZATION OPTIONS:

  • Distributor Landscape Assessment
  • Pricing Intelligence
  • Customer Base Assessment
  • Investment & Initiatives Analysis
  • 'Business Profile' of Key Players

Directly Purchase Premium Copy of Liver Cancer Therapeutics Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=pomPImvLQYnsUbSS2HdnPiXKXUNU2EmLuPV0skOt&report_id=7811&license=Single&submit=

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.


 

            








        

            

                

                    
Tags

                            
                                Liver Cancer Therapeutics
                            

                



        




    

        

        
Contact Data